UnknownNCT03465280
Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
Studying Recurrent respiratory papillomatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Principal Investigator
- Adam DonneAlder Hey Children's NHS Foundation Trust
- Intervention
- Microdebrider(procedure)
- Enrollment
- 400 target
- Eligibility
- All sexes
- Timeline
- 2018 – 2022
Study locations (30)
- NHS Grampian, Aberdeen, United Kingdom
- Betsi Cadwaladr University Health Board,, Bangor, United Kingdom
- Basildon & Thurrock University Hospitals NHS FT, Basildon, United Kingdom
- Belfast Health and Social Care Trust, Belfast, United Kingdom
- University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
- Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom
- Blackpool Teaching Hospital NHS FT, Blackpool, United Kingdom
- Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom
- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- Cardiff and Vale University Local Health Board, Cardiff, United Kingdom
- North Cumbria Univeristy Hospital NHS Trust, Carlisle, United Kingdom
- Hywel Dda University Health Board, Carmarthen, United Kingdom
- County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom
- University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom
- Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, United Kingdom
- +15 more locations on ClinicalTrials.gov
Collaborators
Alder Hey Children's NHS Foundation Trust · National Institute for Health Research, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03465280 on ClinicalTrials.govOther trials for Recurrent respiratory papillomatosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07317154Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) PatientsMayo Clinic
- RECRUITINGEARLY PHASE1NCT04645602Merck IIT: RRP Pembro and LenvatinibYale University
- RECRUITINGPHASE4NCT06538480Zopa Retreatment and Vector Shedding in Adults With RRPPrecigen, Inc
- RECRUITINGNANCT06412172The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)Massachusetts General Hospital
- ACTIVE NOT RECRUITINGPHASE2NCT05797246Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)National Cancer Institute (NCI)
- RECRUITINGNCT06000527Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ")Imagine Institute
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04724980Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory PapillomatosisPrecigen, Inc
- ACTIVE NOT RECRUITINGPHASE2NCT02632344Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma PatientsMassachusetts General Hospital